1. "Neuroradiology Service"
Formats
  1. Journal Article (574)
  2. Meeting Abstract (253)
  3. Book Section (44)
  4. Review (35)
  5. Editorial (10)
  6. Research Letter (8)
  7. Conference Paper (7)
  8. Book Whole (3)
  9. Correspondence (3)
  10. Miscellaneous (2)
  11. Guidelines (1)
Groups
  1. Neuroradiology Service (940)
  2. Radiology, Department of (940)
  3. GSK Faculty (312)
  4. Medical Physics (269)
  5. Department of Medicine (225)
  6. Tow Center for Developmental Oncology (TCDO) (189)

More Groups

People
  1. Robert Young (228)
  2. Andrei Holodny (206)
  3. Sofia Haque (148)
  4. Sasan Karimi (114)
  5. Kyung Peck (108)
  6. Vaios Hatzoglou (97)

More People

Years
  1. 2025 (11)
  2. 2024 (46)
  3. 2023 (49)
  4. 2022 (68)
  5. 2021 (51)
  6. 2020 (61)

More Years

Publications
  1. Neuro-Oncology (97)
  2. Journal of Clinical Oncology (76)
  3. American Journal of Neuroradiology (61)
  4. International Journal of Radiation Oncology, Biology, Physics (46)
  5. Journal of Neuro-Oncology (21)
  6. Journal of Neuroimaging (18)

More Publications

Publishers
  1. Oxford University Press (117)
  2. Elsevier Inc. (107)
  3. Springer (86)
  4. American Society of Clinical Oncology (82)
  5. American Society of Neuroradiology (62)
  6. Wiley Blackwell (55)

More Publishers

Results (940)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker
    Journal Article

    Pietanza, M. C.; Kadota, K.; Huberman, K.; Sima, C. S.; Fiore, J. J.; Sumner, D. K.; Travis, W. D.; Heguy, A.; Ginsberg, M. S.; Holodny, A. I.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Intracranial hemorrhage in patients with cancer treated with bevacizumab: The memorial Sloan-Kettering experience
    Journal Article

    Khasraw, M.; Holodny, A.; Goldlust, S. A.; Deangelis, L. M.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Tumor metabolism and perfusion in head and neck squamous cell carcinoma: Pretreatment multimodality imaging with (1)H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [(18)F]FDG-PET
    Journal Article

    Jansen, J. F. A.; Schoder, H.; Lee, N. Y.; Stambuk, H. E.; Wang, Y.; Fury, M. G.; Patel, S. G.; Pfister, D. G.; Shah, J. P.; Koutcher, J. A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save
  • Metabolic disorders
    Book Section

    Young, R. J.; Haque, S. S.; Lyo, J. K.
    In Law, M.; Som, P. M.; Naidich, T. P. (Eds.) Problem Solving in Neuroradiology (2011)

    Fulltext@MSK | Save
  • A phase II study of VEGF trap in patients with radioactive iodine (RAI)-refractory thyroid carcinoma
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Haque, S.; Tuttle, R. M.; Ghossein, R. A.; Schöder, H.; Baum, M. S.; Kelly, K.; Chen, A. P.; Shaha, A. R.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M. P.; Beal, K.; Karimi, S.; Correa, D.; Chan, T. A.; DeAngelis, L. M.; Gavrilovic, I. T.; Nolan, C.; Hormigo, A.; Lassman, A. B.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • FLAIR, T1 contrast enhancement, MR perfusion, and FDG PET following hypofractionated stereotactic radiotherapy (HFSRT), bevacizumab (BEV), and temozolomide (TMZ) for glioblastoma (GBM)
    Meeting Abstract

    Grommes, C.; Karimi, S.; Beal, K.; Chan, T. A.; Abrey, L. E.; Gutin, P. H.; Omuro, A. M. P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Magnetic resonance (MR) perfusion imaging to differentiate early progression from pseudoprogression following chemoradiotherapy for glioblastoma (GBM)
    Meeting Abstract

    Graber, J. J.; Young, R. J.; Gupta, A.; Shah, A. D.; Chan, T. A.; Zhang, Z.; Shi, W.; Beal, K.; Omuro, A. M. P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A randomized phase II study of cetuximab (C) every 2 weeks at either 500 or 750 mg/m(2) for patients (Pts) with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Lisa, D. M.; Agarwal, N.; Algazy, K. M.; Brockstein, B.; Langer, C. J.; Lim, D.; Mehra, R.; Rajan, S. K.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A phase II trial of ganetespib: Efficacy and safety in patients (pts) with metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Chandarlapaty, S.; Lake, D.; Gilewski, T.; Drullinsky, P.; Sugarman, S.; Wasserheit-Leiblich, C.; Moynahan, M. E.; D'Andrea, G.; Haque, S.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save